Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 8;52(1):218–245. doi: 10.4143/crt.2019.217

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3. — High expression of anterior gradient 3 (AGR3) was associated with poor prognosis in luminal B subtype of invasive ductal carcinoma (IDC) patients of grade I-II. (A) Overall survival (OS) and progression-free survival (PFS) curves of 330 cases of IDC patients were shown, respectively. (B) OS and PFS of 236 luminal patients were shown, respectively. (C) OS and PFS of 66 luminal A patients were shown, respectively. (D) OS and PFS of 170 luminal B patients were shown, respectively. (E) OS and PFS of 88 non-luminal patients were shown, respectively. (F) OS and PFS of 61 triple-negative breast cancer (TNBC) patients were shown, respectively. (G) OS and PFS curves of 261 IDC patients of grade Ⅰ-Ⅱ were shown, respectively. (H) OS and PFS of 197 luminal patients of grade Ⅰ-Ⅱ were shown, respectively. (I) OS and PFS of 55 luminal A patients of grade Ⅰ-Ⅱ were shown, respectively. (J) OS and PFS of 142 luminal B patients of grade Ⅰ-Ⅱ were shown, respectively. (K) OS and PFS of 58 non-luminal patients of grade Ⅰ-Ⅱ were shown, respectively. (L) OS and PFS of 40 TNBC patients of grade Ⅰ-Ⅱ were shown, respectively.